OCREVUS subcutaneous (SC) injection offers a new, 10-minute administration of OCREVUS with comparable efficacy and safety to intravenous infusion (IV)…
COLD SPRING HARBOR, N.Y., June 21, 2024 /PRNewswire/ -- Artificial intelligence continues to squirm its way into many aspects of…
New 5,000-plex gene panel increases plex by an order of magnitude and delivers industry-leading speed and throughput PLEASANTON, Calif., June 20,…
The NeuroCatch Platform, a subsidiary of HealthTech Connex, offers an objective evaluation of cognitive function, delivered in minutes at the…
COLD SPRING HARBOR, N.Y., June 20, 2024 /PRNewswire/ -- It reads. It talks. It collates mountains of data and recommends…
Parkinson’s Disease Clinical Trial Uses Intraoperative MRI to Guide Precision Implantation of Patients’ Own Autologous Replacement NeuronsSOLANA BEACH, Calif., June…
Clinical trial of LX9211, an investigational non-opioid investigational therapy, demonstrated clinically significant benefits for people with diabetic peripheral neuropathic pain…
Fidelity Management & Research Company Leads Financing; Nexus Neurotech Ventures and Ally Bridge Group Co-Lead Robust Investor Syndicate HAIFA, Israel…
Moderated by Emmy award-winning Spectrum News 1 Anchor and National Mental Health Correspondent, Nicole Clark, Ph.D., panel to feature renowned experts…
SAN DIEGO--(BUSINESS WIRE)--Acadia Pharmaceuticals, Inc. (Nasdaq: ACAD) today announced that interim data from the open-label real-world LOTUS™ study will be…